180 Life Sciences Corp (ATNF)
1.53
-0.05
(-3.16%)
USD |
NASDAQ |
May 20, 16:00
1.65
+0.12
(+7.84%)
After-Hours: 07:58
180 Life Sciences Cash and Short Term Investments (Quarterly): 0.676M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.676M |
| December 31, 2023 | 1.976M |
| September 30, 2023 | 2.662M |
| June 30, 2023 | 2.009M |
| March 31, 2023 | 2.646M |
| December 31, 2022 | 6.970M |
| September 30, 2022 | 3.589M |
| June 30, 2022 | 1.625M |
| Date | Value |
|---|---|
| March 31, 2022 | 5.669M |
| December 31, 2021 | 8.224M |
| September 30, 2021 | 11.69M |
| June 30, 2021 | 1.836M |
| March 31, 2021 | 6.053M |
| December 31, 2020 | 2.108M |
| December 31, 2019 | 0.0834M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0834M
Minimum
Dec 2019
11.69M
Maximum
Sep 2021
3.854M
Average
2.646M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Altimmune Inc | 182.02M |
| Seelos Therapeutics Inc | 0.524M |
| GT Biopharma Inc | 9.807M |
| Outlook Therapeutics Inc | 47.23M |
| MAIA Biotechnology Inc | 8.271M |